UNION therapeutics to participate at Kempen Life Science Conference

Tags:  

HELLERUP, Denmark, April 21, 2023 /PRNewswire/ -- UNION therapeutics A/S (UNION), a privately-held, multi-asset, clinical stage, pharmaceutical development company focused on immunology and infectious disease, today announced participation at the Kempen Life Science Conference on April 25-26, 2023, in Amsterdam.

ContactsMorten Boesen, Chief Financial Officer, UNION therapeutics A/S+45 2381 5487[email protected]Sarah Toft-Jørgensen, Director of Communications and IR, UNION therapeutics A/S+45 5385 3044[email protected]

---

---

 About UNION therapeutics

UNION therapeutics is a privately held, mid- to late-stage, pharmaceutical development company advancing novel treatment options within immunology and infectious diseases, two large and fast-growing therapeutic areas. UNION is headquartered in Hellerup, Denmark, and led by an international team combining biotech entrepreneurs and seasoned pharma executives, with a track record of developing and launching more than fifteen marketed drugs. Read more at www.uniontherapeutics.com 

The following files are available for download:

https://mb.cision.com/Main/19591/3756134/2002276.pdf

Release

SOURCE UNION therapeutics

More news releases in similar topics

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Cision Distribution 888-776-0942 from 8 AM - 9 PM ET